EUREGENETHY2: European cooperation network to collect & disperse ethical, safety & regulatory data in order to facilitate clinical implementation of gene transfer technology (gene therapy)

In the rapidly moving area of gene therapy, fast adaptation to evolving knowledge is essential in order to better define ethical & safety provisions. The Euregenethy 2 will continue to focus on the ethical, safety and regulatory issue s related to clinical implementation of gene transfer technology in order to facilitate and help harmonise it. Our current objectives are threefold: (i) Fostering interaction between regulators, scientists and industry; (ii) Offering a potential for a referral organisation following-up on evolving technologies; (iii) Increase public accountability. Means to achieve these goals are: (1) Organisation of focused meetings and maintaining sessions at ESGT; (2) Publication of an annual newsletter; (3) Interactive web-page; (4) Initiate safety & technology data-bases; GT-products & cell biology (including stem cells); (5) Clinical trials data-base including a survey of successful trials.